Sanofi (FRA:SNW2)

Market Cap	96.04B
Revenue (ttm)	45.74B
Net Income (ttm)	9.13B
Shares Out	n/a
EPS (ttm)	7.35
PE Ratio	10.52
Forward PE	9.50
Dividend	1.42 (3.34%)
Ex-Dividend Date	May 9, 2025

Volume	n/a
Average Volume	80
Open	42.40
Previous Close	42.40
Day's Range	42.40 - 42.40
52-Week Range	40.60 - 54.50
Beta	n/a
RSI	54.67
Earnings Date	Jul 31, 2025

About MorphoSys AG

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW2

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.